Glaxosmithkline Plc (GSK)
$37.87 0.73 (1.97%)
15:10 EDT GSK Stock Quote Delayed 20 Minutes
Previous Close $37.14
Market Cap 93.91B
PE Ratio 91.03
Volume (Avg. Vol.) 3.18M
Day's Range 37.37 - 38.04
52-Week Range 31.43 - 48.25
Dividend & Yield 2.14 (5.65%)
GSK Stock Predictions, Articles, and Glaxosmithkline Plc News
- From InvestorPlace
- From the Web
A number of S&P 500 companies have already increased their 2020 dividends by 10% or more. Here are 10 stocks to buy among this group.
Amarin is targeting a huge market, and its main drug -- Vascepa -- is likely to be expanded in its coverage. Here’s a look at what’s ahead for the stock.
Turning Point Brands, Cronos Group and Altria are just some of the stocks to buy or sell here at a pivotal time for vaporizers.
These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward.
Generic drug companies are on discount for investors who want to buy life sciences stocks. Why, and when will this sector recover?
These three biopharma stocks to buy should help investors maintain strength amid any potential chaos in 2019.
GlaxoSmithKline (GSK) stock is up today on news of a new joint venture with Pfizer (PFE) for a consumer healthcare business.
The stock charts of ROST, D and MS are shaping up as the top trading prospects as December's action gets going.
Tesaro stock was flying high on Monday with news that GlaxoSmithKline (GSK) is planning to acquire it in a deal worth $5.10 billion.
These seven healthcare stocks are coming to life Monday. Here's how to play these companies without getting burnt.
GlaxoSmithKline pays shareholders a solid dividend yet the company is not just for income investors. In the next few years, growth in the consumer unit will lead to strong cash flow, raising the chances of dividend hikes for GSK stock.
Small-cap stocks have been on a tear of late. Take the hint, and start your search with these seven top prospects.
International dividend stocks should make up a hefty portion of your portfolio, as you need them to smooth out the sort of stateside volatility we're experiencing right now.
In the first six months of the year, the FDA grants approval to 17 new treatments. Compare Brokers....
Though the large-cap pharma industry is struggling currently, there are a few stocks that are performing well. Compare Brokers....
The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are.
GlaxoSmithKline (GSK) stock was down on Wednesday following the release of an earnings report that misses estimates for the first quarter of 2018.
From The Motley Fool
From Seeking Alpha
Navellier RatingsPowered by Portfolio Grader